The University of Texas Health Science Center at San Antonio
510
86
100
324
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.6%
54 terminated/withdrawn out of 510 trials
85.7%
-0.8% vs industry average
12%
59 trials in Phase 3/4
42%
136 of 324 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (510)
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Role: lead
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
Role: lead
Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
Role: lead
δ in Dementia Clinical Trials
Role: lead
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
Role: lead
Kidney Precision Medicine Project
Role: collaborator
Neurostimulation to Improve NOWS Outcomes
Role: collaborator
SwallowFIT Study in Parkinson's Disease
Role: lead
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
Role: collaborator
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
Role: lead
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
Role: lead
Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD
Role: lead
Quitxt Mobile Text Messaging Cessation Research Study
Role: lead
SGLT2i, Pioglitazone, and Ketone Production in T1D
Role: lead
Sacituzumab Govitecan in Recurrent Glioblastoma
Role: lead
Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion
Role: collaborator
Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement
Role: lead
SGLT2i, Pioglitazone, and Ketone Production in T2D
Role: lead
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Role: lead
Improving Informed Decision Making for Cancer Clinical Trial Participation
Role: lead